Impact of Microbiota Depletion by Antibiotics on SARS-CoV-2 Infection of K18-hACE2 Mice

Patrícia Brito Rodrigues,Giovanni Freitas Gomes,Monara K S C Angelim,Gabriela F Souza,Stefanie Primon Muraro,Daniel A Toledo-Teixeira,Bruna Amanda Cruz Rattis,Amanda Stephane Passos,Laís Passarielo Pral,Vinícius de Rezende Rodovalho,Arilson Bernardo Dos Santos P Gomes,Valquíria Aparecida Matheus,André Saraiva Leão Marcelo Antunes,Fernanda Crunfli,Krist Helen Antunes,Ana Paula Duarte de Souza,Sílvio Roberto Consonni,Luiz Osório Leiria,José Carlos Alves-Filho,Thiago M Cunha,Pedro M M Moraes-Vieira,José Luiz Proença-Módena,Marco Aurélio R Vinolo

DOI: https://doi.org/10.3390/cells11162572

IF: 6

2022-08-18

Cells

Abstract:Clinical and experimental data indicate that severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection is associated with significant changes in the composition and function of intestinal microbiota. However, the relevance of these effects for SARS-CoV-2 pathophysiology is unknown. In this study, we analyzed the impact of microbiota depletion after antibiotic treatment on the clinical and immunological responses of K18-hACE2 mice to SARS-CoV-2 infection. Mice were treated with a combination of antibiotics (kanamycin, gentamicin, metronidazole, vancomycin, and colistin, Abx) for 3 days, and 24 h later, they were infected with SARS-CoV-2 B lineage. Here, we show that more than 80% of mice succumbed to infection by day 11 post-infection. Treatment with Abx had no impact on mortality. However, Abx-treated mice presented better clinical symptoms, with similar weight loss between infected-treated and non-treated groups. We observed no differences in lung and colon histopathological scores or lung, colon, heart, brain and kidney viral load between groups on day 5 of infection. Despite some minor differences in the expression of antiviral and inflammatory markers in the lungs and colon, no robust change was observed in Abx-treated mice. Together, these findings indicate that microbiota depletion has no impact on SARS-CoV-2 infection in mice.